Suzhou Basecare Medical Corp. Ltd. Class H (HK:2170) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Suzhou Basecare Medical Corp. Ltd. has received approval from China’s National Medical Products Administration to renew the registration of its innovative PGT-A kit until 2030. This renewal underscores the kit’s proven clinical efficacy, having demonstrated 100% concordance in over 100,000 clinical samples. The PGT-A kit is a significant advancement in the field of genetic testing in China, providing accurate analysis for embryo implantation decisions.
For further insights into HK:2170 stock, check out TipRanks’ Stock Analysis page.